Topics
Latest
AI
Amazon
Image Credits:Dimension / Travis Pitcher
Apps
Biotech & Health
Climate
Image Credits:Dimension / Travis Pitcher
Cloud Computing
Commerce
Crypto
Enterprise
EVs
Fintech
fund raise
widget
Gaming
Government & Policy
Hardware
layoff
Media & Entertainment
Meta
Microsoft
Privacy
Robotics
Security
Social
Space
Startups
TikTok
Department of Transportation
Venture
More from TechCrunch
case
Startup Battlefield
StrictlyVC
Podcasts
Videos
Partner Content
TechCrunch Brand Studio
Crunchboard
Contact Us
Many VCs , particularly new firms , promptly allow in that 2024 has been a thought-provoking year for raising fresh Washington .
Dimension Capital , a two - year - honest-to-goodness venture outfit , had a different experience when raising its second fund .
“ Every investor from fund one come back very quickly , ” said Zavian Dar ( figure center ) , one of the firm ’s three founders and do partners . Dimension also fetch in a low number of new investor , but terminate up “ turning off the immense majority of LPs who utter interest . ”
attribute ’s appeal is its unique focal point on investing at the nexus of life skill and technology , an area that has gained popularity in late years as the hope of drug discovery with artificial intelligence ( alongside a full-grown button to work up AI into amoreclinical applications)seems closer than ever . In fact , Dar claims that the outfit is the first VC firm dedicated solely to “ bridging the gap ” between biology and computer science .
Since its founding in 2022 by Dar , who was antecedently a general partner at Lux Capital ; another Lux investor , Adam Goulburn ( visualise on the rightfield ) ; and Obvious Ventures alumnus Nan Li ( fancy on the left wing ) , Dimension has adorn in about 20 companies . About one-half of Dimension ’s startup are still in stealth .
As for the firm ’s known portfolio company , they include Chai Discovery , a inauguration that ’s grow an open - sourced AI foundational mannikin for drug discovery . In September , Chai raised $ 30 million in seed funding go by Thrive Capital and OpenAI , with Dimension ’s participation . The firm has also backedEnveda Biosciences , a biotech that uses AI to develop medication from natural compounds , which raised a$130 million Series Clast calendar month .
Join us at TechCrunch Sessions: AI
Exhibit at TechCrunch Sessions: AI
When the house first found , the mate said they were focusing primarily on early - stage investment . But the focus has since expanded to all stages of growing , from origination to public companies . Dimension invested in Monte Rosa , a in public - trade biotechnology with that uses AI cock for drug development .
The leg - agnostic approach means that Dimension can write check as small as a million and as much as $ 30 million or more . And just like its first investment firm , the second will in all probability have about 20 portfolio company .
Dimension ’s current portfolio is close to split between drug discovery companies and package and infrastructure companies support biopharma , such as a still - stealth startup that builds robots for automating laboratory experiment .
Dimension Capital declined to disclose names of LPs but said more generally that the list include endowments , infirmary , and inquiry institutions , among others .
Unlike many traditional spirit sciences VCs , Dimension will invest in biotech startup only if “ 25 % , 30 % , even 40 % of the squad are computational biologists , ” Goulburn say . “ They ’re machine see practician , AI engineers , hardware roboticists that are immingle and symbiotically working together with pharmacist and biologists to do the drug uncovering . ”
Dar said he has been impress with the founder who choose to start businesses in the sphere .
“ One of the astonishing things about this consequence is the caliber of entrepreneur , ” Dar said . “ These extremely ambitious , expert , scientifically literate individuals are all entering this bowl . ”
